arrow
G

Gaëlle Pierron

Institut Curie
H指数:63
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Molecular evolution of mosaic chromosome 18 copy-number alterations from gametes to hepatoblastoma

嵌合染色体18在配子到肝母细胞瘤过程中的分子进化及拷贝数改变

2026-04-200
OAAI
Multi-omics profiling identified two epithelioid sarcoma molecular subtypes with distinct signaling and immune characteristics

多组学分析鉴定出两种具有不同信号通路和免疫特征的上皮样肉瘤分子亚型

2025-11-280
OAAI
Interest of a sequential multimodal approach for the treatment of newly diagnosed patients with multimetastatic Ewing sarcoma: results of the French prospective CombinaiR3 phase II trial

对于新诊断的多发性转移性尤因肉瘤患者,采用序贯多模式治疗方法的临床价值:法国前瞻性CombinaiR3 II期试验结果

2025-11-170
PRE
Genetic background predicts uveal melanoma patients’ outcomes

遗传背景预测葡萄膜黑色素瘤患者的预后

2025-10-100
OAAI
Atypical Neuroblastoma With Absent Urinary Catecholamine Excretion and 123ImIBG Avidity Are of Favorable Outcome: A Retrospective French Single-Center Study

非典型神经母细胞瘤伴尿儿茶酚胺排泄缺失和123I-mIBG摄取增强者预后良好:一项回顾性法国单中心研究

2025-09-010
OAAI
Ultrasound-guided core-needle biopsy for extra-ocular orbital soft tissue tumours: a minimally invasive alternative to surgical biopsy

超声引导下核心针活检术用于眼外眶内软组织肿瘤:微创替代手术活检的方法

2024-11-120
PRE
Phenotypic and epigenetic heterogeneity in FGFR2-fused glial and glioneuronal tumours
2024-11-070
OAAI
CIC/ATXN1-rearranged tumors in the central nervous system are mainly represented by sarcomas: A comprehensive clinicopathological and epigenetic series

中枢神经系统中的CIC/ATXN1-rearranged肿瘤主要以肉瘤为代表: 全面的临床病理和表观遗传学系列

2024-10-230
OAAI
Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafusp
2024-10-140
OAAI
Cellular origin and clonal evolution of human dedifferentiated liposarcoma
2024-09-122
OAAI
Clonal decomposition and DNA replication states defined by scaled single-cell DNA and RNA sequencing suggest clone-specific therapeutic vulnerabilities in neuroblastoma
2024-09-050
PRE
Targeting boundary cap cells leads to mouse Smarcb1-deficient peripheral nerve tumors recapitulating human peripheral rhabdoid tumors
2024-09-050
PRE
Multimodal therapy in first line treatment of very high risk Ewing sarcoma patients: Results of the French prospective multicenter COMBINAIR3 phase II trial

多模态疗法在超高危尤因肉瘤患者一线治疗中的应用:法国前瞻性多中心COMBINAIR3 II期试验的结果

2024-09-010
PRE